Jump to content

Protecting Against Serious Chemotherapy Side Effect

Recommended Posts

Protecting Against Serious Chemotherapy Side Effect

16 Jul 2006

Every year, Over one million cancer patients in the u.s. receive chemotherapy. One serious side effect of chemotherapy is neutropenia, a shortage of infection-fighting white blood cells. Complications associated with neutropenia can delay a patient's chemotherapy or keep them from getting a full dose.

Dr. Michael rader, assistant professor columbia university medical center:

"With sufficient white blood cells, patients have a better chance of adhering to their chemotherapy schedule, giving them the best chance for successful treatment. Using Neulasta, a medication that increases white blood cell count, from the start of chemotherapy can help protect patients from neutropenia."

Neulasta helps protect patients against chemotherapy related Complications and significantly reduces the risk of infection and incidence of hospitalization related to neutropenia.

Rare cases of splenic rupture and allergic reactions, including Anaphylaxis, have been reported in postmarketing experience. Rarely, these allergic reactions recurred within days after discontinuing anti-allergic treatment. For more information, visit http://www.neulasta.com or speak to your healthcare professional.



Article URL: http://www.medicalnewstoday.com/medical ... wsid=47220

Save time! Get the latest medical news headlines for your specialist area, in a weekly newsletter e-mail. See http://www.medicalnewstoday.com/newsletters.php for details.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.